Engineering adoptive T cell therapy for efficacy in ovarian cancer

被引：0
|
作者：
Anderson, Kristin G.
Bates, Breanna M.
Chiu, Edison Y.
Greenberg, Philip D.
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-4980
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4980
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Adoptive T cell therapy: engineering and biomanufacturing chimeric antigen receptor-T cell
    Jenkins, Jackson
    Park, Jaeyoung
    Petersen, Kristen
    Shajihan, Kahmil
    Kruthiventi, Srivalli
    Betenbaugh, Michael
    CURRENT OPINION IN CHEMICAL ENGINEERING, 2018, 22 : 26 - 33
  • [32] PRIMING OF HOST T CELL MEMORY IS REQUIRED FOR THE EFFICACY OF ADOPTIVE CELL THERAPY
    Flores, Catherine
    Abraham, Rebecca
    Mitchell, Duane
    NEURO-ONCOLOGY, 2016, 18 : 97 - 97
  • [33] Adoptive T Cell Immunotherapy Strategies for the Treatment of Patients with Ovarian Cancer
    Chekmasova, Alena A.
    Brentjens, Renier J.
    DISCOVERY MEDICINE, 2010, 9 (44) : 62 - 70
  • [34] Adoptive T cell therapy
    Blankenstein, T.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2018, 26 : 20 - 20
  • [35] TRIPLE CHECKPOINT BLOCKADE, BUT NOT ANTI-PD1 ALONE, ENHANCES THE EFFICACY OF ENGINEERED ADOPTIVE T CELL THERAPY IN ADVANCED OVARIAN CANCER
    Anderson, Kristin
    Su, Yapeng
    Burnett, Madison
    Bates, Breanna
    Suarez, Magdalia Rodgers
    Ruskin, Susan
    Vakil, Aesha
    Voillet, Valentin
    Gottardo, Raphael
    Greenberg, Philip
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A590 - A590
  • [36] Triple checkpoint blockade, but not anti-PD1 alone, enhances the efficacy of engineered adoptive T cell therapy in advanced ovarian cancer
    Anderson, Kristin G.
    Su, Yapeng
    Burnett, Madison G.
    Bates, Breanna M.
    Suarez, Magdalia L. Rodgers
    Ruskin, Susan L.
    Voillet, Valentin
    Gottardo, Raphael
    Greenberg, Philip D.
    CANCER RESEARCH, 2024, 84 (05)
  • [37] Triple checkpoint blockade, but not anti-PD1 alone, enhances the efficacy of engineered adoptive T cell therapy in advanced ovarian cancer
    Anderson, Kristin G.
    Su, Yapeng
    Burnett, Madison
    Bates, Breanna
    Suarez, Magdalia Rodgers
    Voillet, Valentin
    Gottardo, Raphael
    Greenberg, Philip D.
    JOURNAL OF IMMUNOLOGY, 2023, 210 (01):
  • [38] Triple checkpoint blockade, but not anti-PD1 alone, enhances the efficacy of engineered adoptive T cell therapy in advanced ovarian cancer
    Anderson, Kristin G.
    Su, Yapeng
    Burnett, Madison G.
    Bates, Breanna M.
    Suarez, Magdalia L. Rodgers
    Ruskin, Susan L.
    Vakil, Aesha
    Voillet, Valentin
    Gottardo, Raphael
    Greenberg, Philip
    CANCER RESEARCH, 2022, 82 (12)
  • [39] A universal killer T-cell for adoptive cell therapy of cancer
    Dillard, Pierre
    Mensali, Nadia
    Myklebust, June Helen
    Hebeisen, Mickael
    Skorstad, Gjertrud
    Myrhe, Marit Renee
    Fane, Anne
    Gaudernack, Gustav
    Kvalheim, Gunnar
    Inderberg, Else Marit
    Walchli, Sebastien
    CANCER RESEARCH, 2018, 78 (13)
  • [40] A universal killer T-cell for adoptive cell therapy of cancer
    Walchli, S.
    Inderberg, E. M.
    Myklebust, J. H.
    Skorstad, G.
    Myhre, M. R.
    Faane, A.
    Gaudernack, G.
    Kvalheim, G.
    ANNALS OF ONCOLOGY, 2015, 26 : 2 - 2
12345